Literature DB >> 8626378

Peroxynitrite inhibits glutamate transporter subtypes.

D Trotti1, D Rossi, O Gjesdal, L M Levy, G Racagni, N C Danbolt, A Volterra.   

Abstract

The reuptake of glutamate in neurons and astrocytes terminates excitatory signals and prevents the persistence of excitotoxic levels of glutamate in the synaptic cleft. This process is inhibited by oxygen radicals and hydrogen peroxide (H2O2). Here we show that another biological oxidant, peroxynitrite (ONOO-), formed by combination of superoxide (O2-) and nitric oxide (NO), potently inhibits glutamate uptake by purified or recombinant high affinity glutamate transporters reconstituted in liposomes. ONOO- reduces selectively the Vmax of transport; its action is fast (reaching > or = 90% within 20 s), dose-dependent (50% inhibition at 50 microM), persistent upon ONOO- (or by product) removal, and insensitive to the presence of the lipid antioxidant vitamin E in the liposomal membranes. Therefore, it likely depends on direct interaction of ONOO- with the glutamate transporters. Three distinct recombinant glutamate transporters from the rat brain, GLT1, GLAST, and EAAC1, exhibit identical sensitivity to ONOO . H2O2 also inhibits reconstituted transport, and its action matches that of ONOO- on all respects; however, this is observed only with 5-10 mM H202 and after prolonged exposure (10 min) in highly oxygenated buffer. NO, released from NO donors (up to 10 mM), does not modify reconstituted glutamate uptake, although in parallel conditions it promotes cGMP formation in synaptosomal cytosolic fraction. Overall, our results suggest that the glutamate transporters contain conserved sites in their structures conferring vulnerability to ONOO- and other oxidants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626378     DOI: 10.1074/jbc.271.11.5976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Structural features of the glutamate transporter family.

Authors:  D J Slotboom; W N Konings; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

2.  Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice.

Authors:  C Ayata; G Ayata; H Hara; R T Matthews; M F Beal; R J Ferrante; M Endres; A Kim; R H Christie; C Waeber; P L Huang; B T Hyman; M A Moskowitz
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

3.  Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.

Authors:  Randall L Woltjer; Kevin Duerson; Joseph M Fullmer; Paramita Mookherjee; Allison M Ryan; Thomas J Montine; Jeffrey A Kaye; Joseph F Quinn; Lisa Silbert; Deniz Erten-Lyons; James B Leverenz; Thomas D Bird; David V Pow; Kohichi Tanaka; G Stennis Watson; David G Cook
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

Review 4.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

5.  MK-801 effect on regional cerebral oxidative stress rate induced by different duration of global ischemia in gerbils.

Authors:  Vesna Selakovic; Branka Janac; Lidija Radenovic
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

6.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

7.  Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidants.

Authors:  H T Rupniak; K A Joy; C Atkin; G Brown; J C Barnes; S R Doctrow; B Malfroy; T Wong; I K Anderson; C R Molloy; G I Mills; P Soden
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 8.  Autoimmune modulation of astrocyte-mediated homeostasis.

Authors:  Thomas Korn; Mahendra Rao; Tim Magnus
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

9.  Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis.

Authors:  Mustapha Najimi; Xavier Stéphenne; Christine Sempoux; Etienne Sokal
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice.

Authors:  T Doyle; E Esposito; L Bryant; S Cuzzocrea; D Salvemini
Journal:  Neuroscience       Date:  2013-02-27       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.